Surgical Innovations Unit, Westmead Hospital, Sydney, New South Wales, Australia.
Western Clinical School, Faculty of Medical and Health Sciences, The University of Sydney, Sydney, New South Wales, Australia.
ANZ J Surg. 2022 Jun;92(6):1338-1346. doi: 10.1111/ans.17417. Epub 2021 Dec 22.
Postoperative pancreatic fistula (POPF) remains a significant complication of pancreatic resection with recent evidence showing a strong association between post-operative pancreatitis and subsequent development of POPF. Incidence and severity of pancreatitis following endoscopic therapy has been effectively reduced with indomethacin prophylaxis, however further agents require evaluation. We present a systematic literature review and meta-analysis of the prophylactic treatment with corticosteroids or n-acetyl cysteine (NAC) of induced pancreatitis in rodent models.
A systematic literature search was conducted using Pubmed, Medline, Embase and Cochrane library to identify eligible randomized control trials (RCT) involving animal models that examined NAC or corticosteroids. The primary outcome was the subsequent effect on serum amylase and IL-6 and the histopathological markers of severity such as pancreatic oedema and necrosis.
Four RCTs (n = 178) met inclusion criteria examining NAC and eight RCTs (n = 546) examining corticosteroid agents (dexamethasone, hydrocortisone, methylprednisolone). Prophylactic administration of all corticosteroid agents showed a net effect in favour of reducing markers of severity of pancreatitis. NAC showed a significant reduction in severity of amylase and necrosis.
The RCTs examined suggest that prophylactic administration of corticosteroid agents and NAC can reduce the severity of pancreatitis as indicated by histopathologic markers, serum amylase and IL-6 levels.
术后胰腺瘘(POPF)仍然是胰腺切除术后的一个重要并发症,最近的证据表明术后胰腺炎与随后发生 POPF 之间存在很强的关联。内镜治疗后胰腺炎的发生率和严重程度已通过吲哚美辛预防得到有效降低,但仍需要评估其他药物。我们对皮质类固醇或 N-乙酰半胱氨酸(NAC)预防诱导性胰腺炎的随机对照试验(RCT)进行了系统文献回顾和荟萃分析。
使用 Pubmed、Medline、Embase 和 Cochrane 图书馆进行系统文献检索,以确定涉及检查 NAC 或皮质类固醇的动物模型的合格随机对照试验(RCT)。主要结局是血清淀粉酶和 IL-6 的后续影响以及胰腺水肿和坏死等严重程度的组织病理学标志物。
四项 RCT(n=178)符合纳入标准,检查 NAC,八项 RCT(n=546)检查皮质类固醇药物(地塞米松、氢化可的松、甲泼尼龙)。所有皮质类固醇药物的预防性给药均显示有利于降低胰腺炎严重程度的净效应。NAC 显著降低了淀粉酶和坏死的严重程度。
检查的 RCT 表明,皮质类固醇药物和 NAC 的预防性给药可以通过组织病理学标志物、血清淀粉酶和 IL-6 水平来降低胰腺炎的严重程度。